Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression
A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort
- To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
- To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Detaillierte Beschreibung
This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Muxuan Chen, Doctor
- Telefonnummer: +8613580561916
- E-Mail: muxuanchen@126.com
Studienorte
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China
- Peking University First Hospital
-
Kontakt:
- Bingbing Xiao, Doctor
-
-
Fujian
-
Fuzhou, Fujian, China
- Fujian Maternity and Child Health Hospital
-
-
Gansu
-
Lanzhou, Gansu, China
- The First Hospital of Lanzhou University
-
Kontakt:
- Haitao Yu, Doctor
-
Lanzhou, Gansu, China
- Gansu Provincial Hospital
-
Kontakt:
- Lianhua Wei, Doctor
-
-
Guangdong
-
Chaozhou, Guangdong, China
- Chaozhou Central Hospital
-
Kontakt:
- Fen lin, Doctor
-
Foshan, Guangdong, China
- Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
-
Kontakt:
- Chaoxin Jiang, Doctor
-
Guangzhou, Guangdong, China
- The First Affiliated Hospital, Sun Yat-sen University
-
Kontakt:
- Bin Huang, Doctor
-
Guangzhou, Guangdong, China
- Nanfang Hospital, Southern Medical University
-
Kontakt:
- Dehua Sun, Doctor
-
Guangzhou, Guangdong, China
- The Fifth Affiliated Hospital of Southern Medical University
-
Kontakt:
- Xiaoyan Li, Doctor
-
Guangzhou, Guangdong, China
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Kontakt:
- Yingchun Zhou, Doctor
-
Guangzhou, Guangdong, China
- The Fifth Affiliated Hospital of Guangzhou Medical University
-
Kontakt:
- Liang Peng, Doctor
-
Guangzhou, Guangdong, China
- The Third Affiliated Hospital of Southern Medical University
-
Kontakt:
- Xuefeng Wang, Doctor
-
Guangzhou, Guangdong, China
- The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Kontakt:
- Kewei Zhao, Doctor
-
Guangzhou, Guangdong, China
- Zhujiang Hospital of Southern Medical University
-
Guangzhou, Guangdong, China
- Guangzhou Baiyun District Taihe People's Hospital
-
Huizhou, Guangdong, China
- Huizhou Municipal Central Hospital
-
Kontakt:
- Xianjin Wu, Doctor
-
Shaoguan, Guangdong, China
- Yuebei People's Hospital
-
Kontakt:
- Pingsen Zhao, Doctor
-
Shenzhen, Guangdong, China, 518028
- Shenzhen Maternity & Child Healthcare Hospital
-
Kontakt:
- Yuting Dai
- Telefonnummer: 0755-82869849
-
Shenzhen, Guangdong, China
- Luohu District People's Hospital
-
Shenzhen, Guangdong, China
- Southern Medical University Shenzhen Hospital
-
Kontakt:
- Hongwei Zhou, Doctor
-
Shenzhen, Guangdong, China
- The Seventh Affiliated Hospital, Sun Yat-sen University
-
Kontakt:
- Zhaofan Luo, Doctor
-
Zhongshan, Guangdong, China
- Zhongshan Xiaolan People's Hospital
-
Kontakt:
- Wandang Wang, Doctor
-
Zhuhai, Guangdong, China
- Zhuhai Maternal and Child Health Hospital
-
-
Guangxi
-
Nanning, Guangxi, China
- The First Affiliated Hospital of Guangxi Medical University
-
Kontakt:
- Faquan Lin, Doctor
-
-
Guizhou
-
Guiyang, Guizhou, China
- Affiliated Hospital of Guizhou Medical University
-
Kontakt:
- Fan Lu, Doctor
-
Zunyi, Guizhou, China
- Zunyi First People's Hospital
-
Kontakt:
- Kaifeng Wu, Doctor
-
-
Hainan
-
Haikou, Hainan, China
- Hainan General Hospital
-
Kontakt:
- Bo Wang, Doctor
-
-
Heilongjiang
-
Mudanjiang, Heilongjiang, China
- Hongqi Hospital Affiliated to Mudanjiang Medical University
-
Kontakt:
- Chunxia Guo, Doctor
-
Qiqihar, Heilongjiang, China
- Qiqihar First Hospital
-
-
Henan
-
Zhengzhou, Henan, China
- Henan Provincial People's Hospital
-
Kontakt:
- Jing Zhao, Doctor
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, China
- Inner Mongolia Autonomous Region Maternal and Child Health Hospital
-
Kontakt:
- Jing Sha, Doctor
-
-
Jiangsu
-
Lianyungang, Jiangsu, China
- The Second People's Hospital of Lianyungang
-
Kontakt:
- Wei Liang, Doctor
-
-
Jilin
-
Jilin City, Jilin, China
- Jilin City Central Hospital
-
Kontakt:
- Guijie Zhang, Doctor
-
-
Liaoning
-
Shenyang, Liaoning, China
- The First Hospital of China Medical University
-
Kontakt:
- Ruizhe Wang, Doctor
-
-
Ningxia
-
Yinchuan, Ningxia, China
- General Hospital of Ningxia Medical University
-
Kontakt:
- Feng Li, Doctor
-
-
Qinghai
-
Xining, Qinghai, China
- Qinghai Red Cross Hospital
-
Kontakt:
- Dengyun Ma, Doctor
-
-
Shandong
-
Jinan, Shandong, China
- Jinan Central Hospital
-
Kontakt:
- Shuyi Han, Doctor
-
Jinan, Shandong, China
- Shandong Provincial Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China
- Shanghai East Hospital, Tongji University
-
Kontakt:
- Jingxin Cheng, Doctor
-
-
Shanxi
-
Changzhi, Shanxi, China
- Changzhi People's Hospital
-
Kontakt:
- Guoxiang Zhang, Doctor
-
-
Sichuan
-
Dazhou, Sichuan, China
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital
-
Kontakt:
- Xuesu He, Doctor
-
Luzhou, Sichuan, China
- Affiliated Hospital of Southwest Medical University
-
Kontakt:
- Jinbo Liu, Doctor
-
-
Tibet
-
Lhasa, Tibet, China
- Tibet Autonomous Region People's Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.
Beschreibung
Inclusion Criteria:
- Female aged 18 to 60 years.
- Participants who previously participated in the baseline of the CALM2004 study.
- Volunteers who are recruited through targeted invitations and consent to participate in this study.
Exclusion Criteria:
- Pregnant women.
- Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
- Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Anzahl der Gruppen / Kohorten
Kohorten und Interventionen
Gruppe / KohorteGruppe / Kohorte |
|---|
|
CALM2004 Follow-up Cohort
A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cumulative incidence of CIN2+ at 5 years
Zeitfenster: 5 years
|
The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline |
5 years
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
New incidence and progression rates of ASC-US+ cytological abnormalities
Zeitfenster: 5 years
|
ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology. |
5 years
|
Andere Ergebnismessungen
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Zeitfenster: 5 years
|
HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up. |
5 years
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Studienstuhl: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Urogenitale Erkrankungen
- Genitalerkrankungen
- Pathologische Prozesse
- Krankheitsattribute
- Infektionen
- Viruserkrankungen
- Übertragbare Krankheiten
- Sexuell übertragbare Krankheiten, viral
- DNA-Virusinfektionen
- Tumorvirusinfektionen
- Pathologische Zustände, Anzeichen und Symptome
- Sexuell übertragbare Krankheiten
- Papillomavirus-Infektionen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- CALM2004-5
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .